Tanggungan utang jangka dawa perusahaan: Thermo Fisher Corp (TMO)

Thermo Fisher Scientific (TMO) generates revenue through the supply of laboratory reagents for the global Life Sciences sector. The company's long-term debt dynamics demonstrate the scale of its expansion via acquisitions to capture the biotechnology market. The value of 36.32 reflects the latest credit portfolio metric. Continuous developments in mass spectrometry and high-precision analytical equipment support the business's resilience.

This indicator measures the volume of borrowed funds with a maturity period exceeding one year, determining the long-term financial stability and investment potential of the business. For Thermo Fisher Scientific (TMO), borrowings support expansion, which the company easily services thanks to significant pricing power and the ability to index prices for critical equipment. By analyzing the company's long-term debt levels, an investor can assess the balance between leverage and organic growth. The stable trend of this metric confirms the effectiveness of the capital expenditure strategy while maintaining high liquidity.